Besides, in vivo experiments showed that there were more numbers of CD206+ and Iba1+ co-labeled microglia/macrophages around the glioma in the JWH133-treated group than in Vehicle group (**P < 0.01 vs. Vehicle; Figures 1C, D). This evidence concerns the gene MRC1 and central nervous system cancer.